Xuya Xiao

Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C

Robert F. Chew, R. Moffitt, M. Haendel, 2023, medRxiv.

Potential drug–drug interactions among U.S. adults treated with nirmatrelvir/ritonavir: A cross‐sectional study of the National Covid Cohort Collaborative (N3C)

H. Mehta, Xuya Xiao, Jill Curran, 2023, Pharmacotherapy.